Pharmacy Remuneration Adjustment Faces Criticism Amid Increased Discounts

German pharmacies are responding to the government's recent cabinet decision to adjust the fixed remuneration per prescription, a measure intended to address the economic pressures faced by the sector. The decision, which follows prolonged negotiations and delays, is seen as a positive step in principle. However, pharmacy organizations express concern that the measure falls short of fully offsetting the cost increases and inflation that pharmacies have absorbed in recent years.

The main issue raised by pharmacy associations is the timing and scale of the adjustment. While the agreed changes to the fixed fee are set to be implemented, representatives argue that the increments are insufficient to cover the real rise in operating costs. Delays in the full enactment of the adjustment further reduce its intended impact, as economic pressures on pharmacies have compounded over successive years.

Complicating the situation is the planned simultaneous increase in the mandatory discount that pharmacies must grant to statutory health insurance funds. Pharmacy associations warn that the benefit of an increased fixed fee could be largely canceled out if the corresponding discount is also raised. This could leave pharmacies facing ongoing financial strain, despite the appearance of reform at the policy level.

Pharmacy stakeholders are calling for a more transparent and objective process in determining future payment structures. They emphasize the need for long-term economic stability, rather than provisional measures that may not provide the necessary support. According to industry representatives, the current approach risks undermining the reliability and financial viability of local pharmacies, which play a central role in Germany's healthcare system.

In addition to the concerns about remuneration and discounts, pharmacy associations have highlighted related issues arising from recent health policy reforms. For example, rising co-payments for patients under the statutory health insurance system have led to increased administrative burdens for pharmacies. Some regional associations advocate for reforms that would relieve pharmacies from acting as collection points for these payments, arguing that such tasks add to their workload without corresponding compensation.

Recent communications from pharmacy organizations also warn of potential negative consequences if the planned increase in the discount to health insurers is implemented as proposed. In open letters to policymakers, associations have described the move as a direct threat to the survival of many local pharmacies, citing the risk of further closures and reduced access to pharmaceutical services in communities across the country.

The debate over the structure of pharmacy remuneration and associated discounts is part of a broader discussion on health sector savings and efficiency measures. Proposals by the national health finance commission, including staggered increases to the fixed fee and the reallocation of funds intended for pharmaceutical services, have been met with resistance by sector representatives. Pharmacy associations argue that piecemeal or symbolic adjustments do not address the underlying challenges and instead call for comprehensive reforms that ensure sustainable funding for essential pharmacy services.

In summary, the government's latest move to adjust the fixed remuneration for pharmacies has been met with cautious acknowledgment but also significant criticism from the sector. Pharmacy organizations continue to urge policymakers to prioritize economic stability and transparency in future reforms, warning that without such measures, the viability of local pharmacies and the broader pharmaceutical care infrastructure may be at risk.